Indefinite Delivery Contract HHSO100201500032C
Award Date
9/30/15
Last Date to Order
11/30/20
Awardee
Sri International
Ultimate Awardee
Not listed
NAICS Category
541711 - Research and Development in Biotechnology
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Pricing Type
Cost Plus Fixed Fee
Legislative Mandate
Not listed
National Interest Action
None
Award Type
Single
Primary Consortia Member
Not listed
Similar IDVs
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response (ASPR), a civilian federal agency, to Southern Research Institute, a non-profit research organization. The contract has a ceiling value of $5,000,000 and a performance period ending on July 13, 2012. The contract aims to procure "OTHER SPECIAL STUDIES AND ANALYSES" for ASPR. Two task orders have been issued under this IDC to date, valued at $244,710 and $240,723...
This indefinite delivery contract was awarded by the National Cancer Institute, a component of the U.S. Department of Health and Human Services, to the non-profit research and development institute SRI International. The single-award contract, valued at a ceiling of $12,069,385, is for the analysis and synthesis of GMP and non-GMP bulk drugs and pharmaceutical formulations. With a period of performance running through April 2028, this contract enables the National Cancer Institute to efficiently...
This indefinite delivery contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to Sri International, a non-profit research and development organization. The contract, with a ceiling value of $9,900,000, has an ultimate completion date of September 26, 2028. The purpose of this IDC is to obtain research and development services to support preclinical pharmacokinetic and pharmacology evaluations of agents being...
This indefinite delivery contract (IDC) was awarded by the National Institute of Allergy and Infectious Diseases (NIAID), a component of the U.S. Department of Health and Human Services, to the IIT Research Institute (IITRI), a subsidiary of the Illinois Institute of Technology. The contract has a ceiling value of $146.3 million and a period of performance through July 2031. The purpose of this IDC is to provide NIAID with a range of preclinical research services related to the development and...
This Indefinite Delivery Contract (IDC) was awarded by the Office of the Assistant Secretary for Preparedness and Response, a civilian federal agency, to Immunexpress Inc., a for-profit organization, on February 15, 2019. The contract has a ceiling value of $744,739.00 and a period of performance through July 31, 2023. The purpose of this IDC is to procure Immunexpress' near-patient sepsis diagnosis technology using their Septicyte product. This contract aims to support the agency's efforts in...
This Indefinite Delivery Contract (IDC) is a single-award contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Sri International, a non-profit research and development organization. The contract, valued at a ceiling of $342,897, is for the provision of IN VITRO METABOLISM AND NON-CLINICAL ADME STUDIES over a 5-year period of performance from September 27, 2021 to April 25, 2025. The contract was not set aside for any specific business size or socioeconomic...
This indefinite delivery contract was awarded by the Department of Health and Human Services (HHS) National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) to Sri International, a non-profit research institute. The $3.9 million contract supports NCATS' drug development programs by (1) developing and validating sensitive bioanalytical methods to quantify concentrations of novel biologics, (2) developing assays to measure anti-drug antibodies, and (3)...
The National Institute of Allergy and Infectious Diseases has awarded an Indefinite Delivery/Indefinite Quantity contract to Sri International to support medical countermeasure development efforts. Task orders issued to date involve animal model development, efficacy testing, and clinical safety studies for monoclonal antibodies, vaccines, and therapeutics against infectious disease targets. Work is conducted at Sri International's facility in West Menlo Park, California over periods ranging...
The federal contract IDV award is a $499,868 Other Transaction IDV awarded by the Defense Advanced Research Projects Agency (DARPA) to SRI International, a non-profit research and development institute. The contract, titled "EQUIP-A-PHARMA - PHASE 1", does not have a small business set-aside. SRI International, an established provider of scientific, engineering, and technical services to federal agencies, will deliver research and development in support of DARPA's mission. The contract...
This Indefinite Delivery Contract (IDC) was awarded by the National Cancer Institute (NCI), a civilian agency within the U.S. Department of Health and Human Services, to IIT Research Institute (IITRI), a non-profit contract research organization. The contract, with a ceiling value of $0, is part of the Preclinical Agent Development Assays 2012-2016 program and supports preclinical in vitro and in vivo agent development assays. Under this IDC, IITRI provides a range of preclinical research...